ConductScience.org, home

Paper9710666

Antibiotic-selective environments.

Baquero F and 3 others. Clin Infect Dis, 1998. Cited by 154 papers, by iCite.

Cite this record

ConductScience Library. Antibiotic-selective environments. Papers, record 9710666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9710666

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibiotic-selective environments.
PubMed
Journal
Clin Infect Dis
PubMed
Year
1998
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
154
iCite
Relative citation ratio, by iCite
4.36
iCite
Revised in PubMed
2022-04-08
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Baquero FF
2Negri MCM C
3Morosini MIM I
4Blázquez JJ

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
BacteriaMajor topic
Drug Resistance, MicrobialMajor topic
Selection, GeneticMajor topic
Adaptation, Physiological
Animals
Biological Evolution
Humans
Mutation
beta-Lactamases

Source PubMed

Download CSV of topics

Cited by74

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 154 citations.

PMIDTitleJournalYearIn PapersSource
42130556Antibiotic resistance: a case of a chronic maxillofacial osteomyelitis complicating an odontogenic cellulitis.Int J Surg Case Rep2026https://conductscience.org/library/papers/42130556PubMed
42098099Host oxidative stress primes mycobacteria for rapid antibiotic resistance evolution.Nat Commun2026https://conductscience.org/library/papers/42098099PubMed
41557766Linking spatial drug heterogeneity to microbial growth dynamics in theory and experiment.PLoS Comput Biol2026https://conductscience.org/library/papers/41557766PubMed
41457317Contrasting pH optima of β-lactamases CTX-M and CMY influence Escherichia coli fitness and resistance ecology.Appl Environ Microbiol2026https://conductscience.org/library/papers/41457317PubMed
41377970Host oxidative stress primes mycobacteria for rapid antibiotic resistance evolution.Res Sq2025https://conductscience.org/library/papers/41377970PubMed
40859163
In vitro activity of Eravacycline against carbapenem-resistant gram-negative bacilli and associated risk factors for non-susceptible infections from a tertiary hospital in fujian, China from 2021 to 2024.
BMC Microbiol2025https://conductscience.org/library/papers/40859163PubMed
39770848Genetic Characterization, Transmission Pattern and Health Risk Analysis of Intestinal Colonization ESBL-Producing Escherichia coli in Vegetable Farming Population.Microorganisms2024https://conductscience.org/library/papers/39770848PubMed
39390045Predicting future hospital antimicrobial resistance prevalence using machine learning.Commun Med (Lond)2024https://conductscience.org/library/papers/39390045PubMed
38681947[Procalcitonin: The Ideal Biomarker To Guide Initiation, Change and Withdrawal of Antibiotics in Septic Burn Patients?]Ann Burns Fire Disasters2023https://conductscience.org/library/papers/38681947PubMed
38534682In Vitro Microevolution and Co-Selection Assessment of Amoxicillin and Cefotaxime Impact on Escherichia coli Resistance Development.Antibiotics (Basel)2024https://conductscience.org/library/papers/38534682PubMed
37737468Therapeutic potential of low-molecular weight lignin model polymer fractions for treating skin lesions in animals: a pilot study.Vet Res Commun2024https://conductscience.org/library/papers/37737468PubMed
37289837Source-tracking ESBL-producing bacteria at the maternity ward of Mulago hospital, Uganda.PLoS One2023https://conductscience.org/library/papers/37289837PubMed
36257971Biofilm antimicrobial susceptibility through an experimental evolutionary lens.NPJ Biofilms Microbiomes2022https://conductscience.org/library/papers/36257971PubMed
35815680Evolution of β-lactamase-mediated cefiderocol resistance.J Antimicrob Chemother2022https://conductscience.org/library/papers/35815680PubMed
35411153The Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Single-Center Chinese Retrospective Study.Infect Drug Resist2022https://conductscience.org/library/papers/35411153PubMed
35391738Emergence of Resistant Escherichia coli Mutants in Microfluidic On-Chip Antibiotic Gradients.Front Microbiol2022https://conductscience.org/library/papers/35391738PubMed
35327267Nature-Inspired Antimicrobial Surfaces and Their Potential Applications in Food Industries.Foods2022https://conductscience.org/library/papers/35327267PubMed
34055327The integrated management of childhood illness (IMCI) and its potential to reduce the misuse of antibiotics.J Glob Health2021https://conductscience.org/library/papers/34055327PubMed
33993436Impact of spent engine oil contamination on the antibiotic resistome of a tropical agricultural soil.Ecotoxicology2021https://conductscience.org/library/papers/33993436PubMed
33910990Cryptic β-Lactamase Evolution Is Driven by Low β-Lactam Concentrations.mSphere2021https://conductscience.org/library/papers/33910990PubMed

See all 74 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9710666

GET https://conductscience.org/api/papers/v1/9710666/cited_by?page=2